On today’s show, Preston and Stig talk about the current market conditions and how they are positioning their portfolio. In the second half of the show, they talk about previous mastermind picks and how they have performed when compared to the S&P500. IN THIS EPISODE, YOU’LL LEARN: – How Preston and Stig’s previous stock picks
admin
I’ve got a question for you. How many shares are you trading currently on per trade basis? How do you decide that? Well, there’s a lot of people out there that wonder exactly this “How many shares should they trade” Should I trade 2 percent of my account size? Or just always trade 100 shares
In the Century of Biology, it pays to own the future of curing disease at the root.
We hear it all the time: The middle class is shrinking. Wages seem to have been stagnant for decades and American families are struggling with financial insecurity. However, what exactly is the middle class? Who is in it, and who is not? Is it shrinking? What about you? Which income class do you belong to?
DraftKings (NASDAQ:DKNG) stock has a boring scoreboard this year. Year-to-date it’s barely up 4%, which is only a quarter of the S&P 500’s performance. However, this boring score does not reflect the excitement in DKNG stock. Source: Tada Images / Shutterstock.com It has had six rallies, each more than 30%. Two of them were compound
A year ago, electric vehicles (EVs) were a promising sector for investors. But in 2021, that all changed. Sponsors of special purpose acquisition companies (SPACs) flooded the market with new EV stock investments. Some of these, like Lucid Motors (NASDAQ:LCID), have worked out pretty well. Most, however, have been terrible for investors. Unfortunately, Lordstown Motors
Have you been keeping an eye on the developments in the genetic editing space? We have. Source: Shutterstock And recently, CRISPR gene editing pioneer Feng Zhang achieved a breakthrough in CRISPR therapy cell-delivery. Instead of using the “default” Cas9 enzyme, Zhang used a sub-family of the Cas13 enzyme. One that’s just tiny enough to fit
In this article ATVI DELL OTMO Dell CEO Michael Dell speaks during an interview with CNBC on the floor of the New York Stock Exchange, July 2, 2018 Brendan McDermid | Reuters The fourth quarter has just begun, and Wall Street analysts are picking out the companies they believe have potential for the long run.
Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be
With the seemingly worsening crisis of property developer China Evergrande (OTCMKTS:EGRNF), it may be time for investors to at least consider reducing exposure to companies tied to the world’s second-largest economy. Late last week, the Wall Street Journal reported that Evergrande failed to make a scheduled interest payment last Thursday, sparking concerns about a mass
After rising over $100 briefly this year, Cassava Sciences (NASDAQ:SAVA) stock is struggling to rebound. A long document written by the lawyer of a short-seller sent SAVA stock lower. The document challenged the accuracy of some of Cassava’s clinical results Source: Atthapon Raksthaput / Shutterstock.com Cassava has two major clinical studies underway. The top-line data
Listen to Preston’s podcast about studying billionaires here: https://itunes.apple.com/us/podcast/the-investors-podcast/id928933489 Jeff Bezos has been hailed as the richest man in the world, inching out long-time titleholder and Microsoft co-founder Bill Gates. The majority of his earnings came from his online shopping retail site Amazon.com with record-breaking profits from Amazon Prime Day. Huge portions also stemmed from
SoFi Technologies (SOFI) is ready to skyrocket as institutional interest floods in at the technically & fundamentally supported levels the stock has come down to
A futures contract is a standardized, legal agreement to buy or sell an asset at a predetermined price at a specified time in the future. At this specified date, the buyer must purchase the asset and the seller must sell the underlying asset at the agreed-upon price, regardless of the current market price at the expiration
Jeff Bezos, left, and Elon Musk Getty Images; Reuters Elon Musk repeated prior criticisms of fellow billionaire space mogul Jeff Bezos, as their respective companies continue to battle in federal court and in front of regulators. “I think I’ve expressed my thoughts on that front – I think he should put more of his energy
Dutch Bros (NYSE:BROS) went public on Sept. 14 at $23.00 per share and immediately spiked to $43.32 as of Sept. 30. That is a gain of more than 88.3% and has led some to argue that BROS stock is overvalued. Source: Alexander Oganezov / Shutterstock.com I looked at some of the numbers in the initial public
As seen in recent days, even meme stock legend AMC Entertainment (NYSE:AMC) is starting to see the effects of the market growing more risk-averse. Since Sept. 13, shares in AMC stock have pulled back from $51.69, down to around $35.50 per share. Source: viewimage / Shutterstock.com Unfortunately, this may be only the start of AMC’s
Shares in Greenidge Generation (NASDAQ:GREE) popped by 6.81% on Wednesday. That’s good news for investors, after GREE stock spent most of the past three weeks in a skid. In fact, GREE made it into Wednesday’s list of biggest pre-market stock movers. Before it began to lose steam, GREE stock gained as much as 17%. What was
Monty Rakusen | Image Source | Getty Images Company: Huntsman Corp. (HUN) Business: Huntsman Corp. is a global manufacturer of differentiated organic chemical products. The company operates in four segments: Polyurethanes, Performance Products, Advanced Materials, and Textile Effects. The Performance Products segment manufactures amines and maleic anhydrides, including ethylene oxide, propylene oxide, glycols, ethylene dichloride,
In this article COTY ZM MRK DIS RIDE WFC Check out the companies making headlines before the bell: Merck (MRK) – Merck shares surged 7.5% in the premarket after it announced that its experimental Covid-19 pill cut the risk of death and hospitalization by 50% in a late-stage study. Merck plans to file for emergency